Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adrienne Graves takes root on board to help Akorn grow

This article was originally published in Scrip

Executive Summary

Niche generic pharmaceutical company Akorn has appointed Dr Adrienne Graves to its board of directors. Dr Graves is an industry leader in ophthalmology, having served as president and CEO of Santen, the US subsidiary of Santen Pharmaceutical from 2002-2010. She currently serves on the boards of TearLab Corporation, Encore Vision, the American Academy of Opthalmology Foundation and the Pan-American Committee for the Brown University Medical School, plus the advisory board of Amach Capital Partners.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC016593

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel